TheraTraQ Revenue and Competitors

Reading, PA USA

Location

N/A

Total Funding

Pharma

Industry

Estimated Revenue & Valuation

  • TheraTraQ's estimated annual revenue is currently $14.3M per year.(i)
  • TheraTraQ's estimated revenue per employee is $201,000

Employee Data

  • TheraTraQ has 71 Employees.(i)
  • TheraTraQ grew their employee count by 20% last year.

TheraTraQ's People

NameTitleEmail/Phone
1
Director Global MarketingReveal Email/Phone
2
Digital Strategy ManagerReveal Email/Phone
3
Senior Project ManagerReveal Email/Phone
4
ConsultantReveal Email/Phone
5
Project Lead - CellTraQReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$43.2M2156%N/AN/A
#2
$81.8M40710%N/AN/A
#3
$11.7M580%N/AN/A
#4
$1011.8M5034-9%N/AN/A
#5
$44.8M2231%N/AN/A
#6
$13.1M655%N/AN/A
#7
$16.5M8241%N/AN/A
#8
$17.3M86-5%N/AN/A
#9
$67.9M33823%N/AN/A
#10
$14.9M747%N/AN/A
Add Company

What Is TheraTraQ?

TheraTraQ was launched in 2019 and operates as an autonomous division within SAI MedPartners, a leading global strategic intelligence provider to the biopharmaceutical and medial device sectors. Our global team structure leverages highly efficient production operations in India and China combined with client coordination and project management teams based in the U.S. and Europe. Plus, TheraTraQ benefits from the access to, and our insight from, SAI Med's Therapeutic Area Leadership (TAL) teams. TheraTraQ was established with a vision of providing clients with a differentiated, yet cost-effective support capability to generate, monitor and manage competitive intelligence for biopharma and device clients. We apply cutting edge monitoring processes, data analytics and knowledge management to provide solutions which allow accessible, interactive “source of truth” competitive intelligence.

keywords:N/A

N/A

Total Funding

71

Number of Employees

$14.3M

Revenue (est)

20%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M716%N/A
#2
$3.5M718%N/A
#3
$15.7M72-5%N/A
#4
$13.8M7322%N/A
#5
$14.9M736%N/A